Wall Street Analysts Predict a 51.26% Upside in Monopar Therapeutics (MNPR): Here's What You Should Know

Monopar Therapeutics Inc. (MNPR) closed the last trading session at $34.51, gaining 2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $52.20 indicates a 51.3% upside potential.The average comprises five short-term price targets ranging from a low of $37 to a high of $76, with a standard deviation of $15.69. While the lowest estimate indicates an increase of 7.2% from the current p ...